Featured Products

My Quote Request

No products added yet

6505-00-258-7004

20 Products

IRC0N

FERROUS FUMARATE TABLETS,USP

NSN, MFG P/N

6505002587004

NSN

6505-00-258-7004

View More Info

IRC0N

FERROUS FUMARATE TABLETS,USP

NSN, MFG P/N

6505002587004

NSN

6505-00-258-7004

MFG

LAKESIDE LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
TOTAL PRIMARY CONTAINER QUANTITY: 100

125-16

DICYCLOMINE HYDROCHLORIDE SYRUP,USP

NSN, MFG P/N

6505002586989

NSN

6505-00-258-6989

View More Info

125-16

DICYCLOMINE HYDROCHLORIDE SYRUP,USP

NSN, MFG P/N

6505002586989

NSN

6505-00-258-6989

MFG

MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 472.000 MILLILITERS DICYCLOMINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: STERILE
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE

0PHTHAINE

PROPARACAINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP

NSN, MFG P/N

6505002586993

NSN

6505-00-258-6993

View More Info

0PHTHAINE

PROPARACAINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP

NSN, MFG P/N

6505002586993

NSN

6505-00-258-6993

MFG

SQUIBB E R AND SONS INC WORLD HQ

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V PROPARACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE

3-0646-30

PROPARACAINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP

NSN, MFG P/N

6505002586993

NSN

6505-00-258-6993

View More Info

3-0646-30

PROPARACAINE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP

NSN, MFG P/N

6505002586993

NSN

6505-00-258-6993

MFG

SQUIBB E R AND SONS INC WORLD HQ

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/V PROPARACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE

517-0886-10

QUINIDINE SULFATE CAPSULES,USP

NSN, MFG P/N

6505002586994

NSN

6505-00-258-6994

View More Info

517-0886-10

QUINIDINE SULFATE CAPSULES,USP

NSN, MFG P/N

6505002586994

NSN

6505-00-258-6994

MFG

LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: PELLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE

QUINIDINESULFATE

QUINIDINE SULFATE CAPSULES,USP

NSN, MFG P/N

6505002586994

NSN

6505-00-258-6994

View More Info

QUINIDINESULFATE

QUINIDINE SULFATE CAPSULES,USP

NSN, MFG P/N

6505002586994

NSN

6505-00-258-6994

MFG

LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: PELLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE

35-0084-21

NITROFURANTOIN SODIUM FOR INJECTION

NSN, MFG P/N

6505002586995

NSN

6505-00-258-6995

View More Info

35-0084-21

NITROFURANTOIN SODIUM FOR INJECTION

NSN, MFG P/N

6505002586995

NSN

6505-00-258-6995

MFG

PROCTER & GAMBLE PHARMACEUTICALS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 16.000 MILLIGRAMS NITROFURANTOIN SODIUM ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 180.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12

FURADANTIN

NITROFURANTOIN SODIUM FOR INJECTION

NSN, MFG P/N

6505002586995

NSN

6505-00-258-6995

View More Info

FURADANTIN

NITROFURANTOIN SODIUM FOR INJECTION

NSN, MFG P/N

6505002586995

NSN

6505-00-258-6995

MFG

PROCTER & GAMBLE PHARMACEUTICALS INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 16.000 MILLIGRAMS NITROFURANTOIN SODIUM ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 180.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12

73-0055-01

FERROUS FUMARATE TABLETS,USP

NSN, MFG P/N

6505002587004

NSN

6505-00-258-7004

View More Info

73-0055-01

FERROUS FUMARATE TABLETS,USP

NSN, MFG P/N

6505002587004

NSN

6505-00-258-7004

MFG

LAKESIDE LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
TOTAL PRIMARY CONTAINER QUANTITY: 100

5-5018-34

ETHAMBUTOL HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505002587010

NSN

6505-00-258-7010

View More Info

5-5018-34

ETHAMBUTOL HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505002587010

NSN

6505-00-258-7010

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 400.000 MILLIGRAMS ETHAMBUTOL HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

MYAMBUT0L

ETHAMBUTOL HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505002587010

NSN

6505-00-258-7010

View More Info

MYAMBUT0L

ETHAMBUTOL HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505002587010

NSN

6505-00-258-7010

MFG

AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 400.000 MILLIGRAMS ETHAMBUTOL HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

62-5804-09

ACETRIZOATE SODIUM AND POVIDONE INJECTION

NSN, MFG P/N

6505002587021

NSN

6505-00-258-7021

View More Info

62-5804-09

ACETRIZOATE SODIUM AND POVIDONE INJECTION

NSN, MFG P/N

6505002587021

NSN

6505-00-258-7021

MFG

ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 230.000 MILLIGRAMS POVIDONE ACTIVE INGREDIENT AND 530.000 MILLIGRAMS ACETRIZOATE SODIUM ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6

SALPIX

ACETRIZOATE SODIUM AND POVIDONE INJECTION

NSN, MFG P/N

6505002587021

NSN

6505-00-258-7021

View More Info

SALPIX

ACETRIZOATE SODIUM AND POVIDONE INJECTION

NSN, MFG P/N

6505002587021

NSN

6505-00-258-7021

MFG

ORTHO PHARMACEUTICAL CORP OMNI EDUCATION DIV SUB OF JOHNSON AND JOHNSON

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 230.000 MILLIGRAMS POVIDONE ACTIVE INGREDIENT AND 530.000 MILLIGRAMS ACETRIZOATE SODIUM ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6

19-2316T1

ACETRIZOATE SODIUM INJECTION

NSN, MFG P/N

6505002587022

NSN

6505-00-258-7022

View More Info

19-2316T1

ACETRIZOATE SODIUM INJECTION

NSN, MFG P/N

6505002587022

NSN

6505-00-258-7022

MFG

MALLINCKRODT INC ANESTHESIA PRODUCTS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V ACETRIZOATE SODIUM ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6

CYST0K0N

ACETRIZOATE SODIUM INJECTION

NSN, MFG P/N

6505002587022

NSN

6505-00-258-7022

View More Info

CYST0K0N

ACETRIZOATE SODIUM INJECTION

NSN, MFG P/N

6505002587022

NSN

6505-00-258-7022

MFG

MALLINCKRODT INC ANESTHESIA PRODUCTS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 PERCENTAGE, W/V ACETRIZOATE SODIUM ACTIVE INGREDIENT
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6

25-0051-51

NORETHYNODREL AND MESTRANOL EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505002587023

NSN

6505-00-258-7023

View More Info

25-0051-51

NORETHYNODREL AND MESTRANOL EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505002587023

NSN

6505-00-258-7023

MFG

ALMAY INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS NORETHYNODREL ACTIVE INGREDIENT AND 75.000 MICROGRAMS MESTRANOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:ORAL NONCHEWABLE;

EN0VID5MG

NORETHYNODREL AND MESTRANOL EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505002587023

NSN

6505-00-258-7023

View More Info

EN0VID5MG

NORETHYNODREL AND MESTRANOL EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505002587023

NSN

6505-00-258-7023

MFG

SEARLE G D AND CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS NORETHYNODREL ACTIVE INGREDIENT AND 75.000 MICROGRAMS MESTRANOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ADMINISTRATION:ORAL NONCHEWABLE;

4-0022-14

TRIMETHOBENZAMIDE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505002587024

NSN

6505-00-258-7024

View More Info

4-0022-14

TRIMETHOBENZAMIDE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505002587024

NSN

6505-00-258-7024

MFG

HOFFMANN-LA ROCHE INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TRIMETHOBENZAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE

TIGAN

TRIMETHOBENZAMIDE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505002587024

NSN

6505-00-258-7024

View More Info

TIGAN

TRIMETHOBENZAMIDE HYDROCHLORIDE CAPSULES,USP

NSN, MFG P/N

6505002587024

NSN

6505-00-258-7024

MFG

HOFFMANN-LA ROCHE INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS TRIMETHOBENZAMIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE

6-3300-62

CHOLESTYRAMINE RESIN,USP

NSN, MFG P/N

6505002587027

NSN

6505-00-258-7027

View More Info

6-3300-62

CHOLESTYRAMINE RESIN,USP

NSN, MFG P/N

6505002587027

NSN

6505-00-258-7027

MFG

MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 216.000 GRAMS CHOLESTYRAMINE RESIN ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 216.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE